Status
Conditions
Treatments
About
This study aims to investigate the impact of supplementation with two different doses of Rosemary and Daylily herbal extract on various health outcomes in middle-aged adults. Over an eight-week period, the trial will assess improvements in sleep quality, circadian rhythms, energy metabolism, and relevant biochemical markers. The study employs a randomized, placebo-controlled, crossover design to evaluate the efficacy of these supplements in enhancing overall health and well-being.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
10 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Sergej M Ostojic, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal